Literature DB >> 17621479

Phenotype and management of Aicardi syndrome: new findings from a survey of 69 children.

Margaret A K Glasmacher1, V Reid Sutton, Bobbi Hopkins, Tanya Eble, Richard A Lewis, Denise Park Parsons, Ignatia B Van den Veyver.   

Abstract

Aicardi syndrome is a rare neurodevelopmental disorder characterized by agenesis of the corpus callosum, other developmental brain abnormalities, chorioretinal lacunae, and severe seizures. Current clinical knowledge is derived from small series that focus on these major defects. The authors performed a health survey on a large number of affected children to expand this knowledge and to uncover previously unrecognized features of Aicardi syndrome. Responses received from caregivers of 69 children with Aicardi syndrome met inclusion criteria for data analysis. Ages ranged from 5 months to 32 years (mean, 88 months). All subjects were girls, except for 1 boy with a 47,XXY karyotype. The authors found that the growth rate in Aicardi syndrome slows at age 10 years to below the 5th percentile and that weight gain slows at age 7 years to below the 25th percentile. The median age of survival was estimated at 18.5 (+/-4) years, more favorable than previously reported. The most common complication aside from seizures was gastrointestinal dysfunction, present in >90%. The results from this survey contribute new information on Aicardi syndrome that will benefit clinical management, and collected data will benefit phenotype-driven research toward its underlying cause.

Entities:  

Mesh:

Year:  2007        PMID: 17621479     DOI: 10.1177/0883073807300298

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  9 in total

1.  Aicardi syndrome associated with autosomal genomic imbalance: coincidence or evidence for autosomal inheritance with sex-limited expression?

Authors:  P Prontera; A Bartocci; V Ottaviani; I Isidori; D Rogaia; C Ardisia; G Guercini; A Mencarelli; E Donti
Journal:  Mol Syndromol       Date:  2013-04-11

2.  Diagnostic approach to Aicardi syndrome: A case report.

Authors:  Nury Tatiana Rincón Cuenca; María Fernanda Castro Peñaranda; Camilo Andres Calderón Valderrama; Santiago Aristizábal Ortiz; Andrés Felipe Herrera Ortiz
Journal:  Radiol Case Rep       Date:  2022-06-20

3.  A genome-wide screen for copy number alterations in Aicardi syndrome.

Authors:  Xiaoling Wang; V Reid Sutton; Tanya N Eble; Richard Alan Lewis; Preethi Gunaratne; Ankita Patel; Ignatia B Van den Veyver
Journal:  Am J Med Genet A       Date:  2009-10       Impact factor: 2.802

4.  Non-random X chromosome inactivation in Aicardi syndrome.

Authors:  Tanya N Eble; V Reid Sutton; Haleh Sangi-Haghpeykar; Xiaoling Wang; Weihong Jin; Richard A Lewis; Ping Fang; Ignatia B Van den Veyver
Journal:  Hum Genet       Date:  2009-01-01       Impact factor: 4.132

5.  Palliative epilepsy surgery in Aicardi syndrome: a case series and review of literature.

Authors:  Aimen S Kasasbeh; Christina A Gurnett; Matthew D Smyth
Journal:  Childs Nerv Syst       Date:  2013-08-16       Impact factor: 1.475

6.  Independent variant analysis of TEAD1 and OCEL1 in 38 Aicardi syndrome patients.

Authors:  Bibiana K Y Wong; Vernon R Sutton; Richard A Lewis; Ignatia B Van den Veyver
Journal:  Mol Genet Genomic Med       Date:  2017-01-25       Impact factor: 2.183

7.  Aicardi syndrome in a 20-year-old female.

Authors:  Maria A Mavrommatis; Alan H Friedman; Mary E Fowkes; Marco M Hefti
Journal:  Am J Ophthalmol Case Rep       Date:  2018-09-06

8.  Precocious and Early Central Puberty in Children With Pre-existing Medical Conditions: A Single Center Study.

Authors:  Sarah Winter; Adélaïde Durand; Raja Brauner
Journal:  Front Pediatr       Date:  2019-02-14       Impact factor: 3.418

9.  Aicardi-Goutières syndrome-associated mutation at ADAR1 gene locus activates innate immune response in mouse brain.

Authors:  Xinfeng Guo; Clayton A Wiley; Richard A Steinman; Yi Sheng; Beihong Ji; Junmei Wang; Liyong Zhang; Tony Wang; Mazen Zenatai; Timothy R Billiar; Qingde Wang
Journal:  J Neuroinflammation       Date:  2021-07-31       Impact factor: 8.322

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.